---
title: "Neurogene Inc. Stock 12‑Month Price Target Raised to $79.62, Implies 153% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291453877.md"
description: "Neurogene Inc.'s average 12-month price target was raised to $79.62 by 8 analysts, up from $78.75, implying a 153% upside based on the June 30 closing price. The consensus rating remains 'Buy' across 10 covering analysts, with forecasts ranging from $46 to $180 per share."
datetime: "2026-07-01T19:20:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291453877.md)
  - [en](https://longbridge.com/en/news/291453877.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291453877.md)
generator: "portal-rs"
---

# Neurogene Inc. Stock 12‑Month Price Target Raised to $79.62, Implies 153% Upside

-   According to estimates from 8 analysts, Neurogene Inc. stock's average price target has risen from $78.75 to $79.62, with forecasts ranging from $46 to $180 per share
-   Based on the Jun. 30 closing price, the updated target implies approximately 153% potential upside
-   Consensus rating remains at “Buy” across 10 covering analysts, with 10 Buys, 0 Holds and 0 Sells

Explore more price target data and ratings for Neurogene Inc. on the , and track all previous and future analyst recommendations for Neurogene Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [NGNE.US](https://longbridge.com/en/quote/NGNE.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Bank of America Corp DE Trims Stock Holdings in Neurogene Inc. $NGNE](https://longbridge.com/en/news/298796172.md)
- [Neurogene Inc. Stock 12‑Month Price Target Raised to $77.86, Implies 147% Upside](https://longbridge.com/en/news/286292365.md)
- [Apnimed, Inc. reports Q2 results](https://longbridge.com/en/news/298366495.md)
- [Braveheart Bio, Inc. reports Q2 results](https://longbridge.com/en/news/298361396.md)
- [Tecsys Inc. declares CAD 0.09 dividend](https://longbridge.com/en/news/298741855.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**